FiercePharmaAsia—Teva’s China JV? Lupin plants’ roadblock, EOC’s $32M series B

10th November 2017 Uncategorised 0

Teva is reportedly looking to form a Chinese joint venture, two of Lupin’s plants were hit with a combined FDA warning letter, China’s EOC Pharma has raised $32 million to help bring several cancer drugs to market and more.

More: FiercePharmaAsia—Teva’s China JV? Lupin plants’ roadblock, EOC’s M series B
Source: fierce